Panitumumab

Vectibix, concentraat voor oplossing voor infusie

Concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 3 Dec 2007

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VectibixEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Panitumumab

Vectibix, concentraat voor oplossing voor infusie

Concentraat voor oplossing voor infusieNetherlandsAuthorisedAuthorised 3 Dec 2007

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VectibixEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vectibix 20 MG/ML Concentrado Para Solucion Para PerfusionSpain · 20 mg · concentrado para solución para perfusión · Amgen Europe B.V.

VectibixEuropean Union · Amgen Europe B.V.

VectibixCroatia

VectibixItaly · Concentrato per soluzione per infusione · Amgen Europe B.V.

VECTIBIX 20mg/mlRomania · 20mg/ml · conc. pt. sol. perf. · Amgen Europe B.V.

Vectibix®Serbia · 20mg/mL · koncentrat za rastvor za infuziju · Amicus SRB D.O.O.

Vectibix 20MG/ML Conc. Solution for InfusionSaudi Arabia · Amgen Manufacturing Limited

Vectibix Concentrate for Solution for Infusion 100 mg/vialSingapore · 100 mg/vial · infusion, solution concentrate · Amgen Biotechnology Singapore Pte LTD

VectibixUnited States · 10ML/200MG, 20ML/400MG, 5ML/100MG · injectable · Amgen

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Panitumumab
Dosage form: Concentraat voor oplossing voor infusie
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 3 Dec 2007
Registration: EU/1/07/423
Marketing authorisation holder: Amgen Europe B.V.
ATC code: L01FE02
Group: Antineoplastic and immunomodulating agents
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/000741
EU number: EU/1/07/423